Drug used to reduce blood fats may cut SARS-CoV-2 infection by 70 per cent: Study

The team led by researchers from the University of Birmingham in the UK found that fenofibrate and its active form fenofibric acid can significantly reduce SARS-COV-2 infection, that causes COVID-19, in human cells in the laboratory.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rVlGjz
via IFTTT